Autor: "Eymard, B." - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Marathons and myasthenia gravis: a case report.
Autorzy:: Birnbaum S; Institute of Myology, GH Pitié-Salpêtrière (AP-HP), Bd de l'Hôpital, 75651, Paris Cedex 13, France. .; Bioingénierie, Tissus et Neuroplasticité, EA 7377 Université Paris-Est Créteil Faculté de Médecine, 8 rue Jean Sarrail, 94010, Créteil, France. .; Unité de Recherche Clinique Paris Île- de- France Ouest (URC PIFO), Raymond Poincaré Hospital, AP-HP, Garches, France. .
Sharshar T; Medical and Surgical Neurointensive Care Centre, Hospital Sainte Anne, Paris, France.; Laboratory of human histopathology and animal models, Institute Pasteur, Paris, France.; Université Paris Descartes, Paris, France.
Eymard B; Institute of Myology, GH Pitié-Salpêtrière (AP-HP), Bd de l'Hôpital, 75651, Paris Cedex 13, France.
Theaudin M; Department of Neurology, CHUV, Rue du Bugnon, 46 1011, Lausanne, Switzerland.
Portero P; Bioingénierie, Tissus et Neuroplasticité, EA 7377 Université Paris-Est Créteil Faculté de Médecine, 8 rue Jean Sarrail, 94010, Créteil, France.
Hogrel JY; Institute of Myology, GH Pitié-Salpêtrière (AP-HP), Bd de l'Hôpital, 75651, Paris Cedex 13, France.; Pokaż więcej
Źródło:: BMC neurology [BMC Neurol] 2018 Sep 18; Vol. 18 (1), pp. 145. Date of Electronic Publication: 2018 Sep 18.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Myasthenia Gravis/*physiopathology
Running/*physiology
Adult ; Cholinesterase Inhibitors/therapeutic use ; Exercise ; Female ; Humans ; Myasthenia Gravis/drug therapy

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: The benefits and tolerance of exercise in myasthenia gravis (MGEX): study protocol for a randomised controlled trial.
Autorzy:: Birnbaum S; Institute of Myology, Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.; Bioingénierie, Tissus et Neuroplasticité (BIOTN) EA 7377, University Paris-Est, UPEC, Créteil, France.
Hogrel JY; Institute of Myology, Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
Porcher R; Centre de Recherche Épidémiologie et Statistique Sorbonne Paris Cité (CRESS-UMR1153), Hôtel-Dieu, AP-HP, Paris, France.
Portero P; Bioingénierie, Tissus et Neuroplasticité (BIOTN) EA 7377, University Paris-Est, UPEC, Créteil, France.; Rothschild Hospital, AP-HP, Paris, France.
Clair B; Intensive Care Unit, Raymond Poincaré Hospital, AP-HP, Garches, France.
Eymard B; Institute of Myology, Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
Demeret S; Neurological Intensive Care Unit, Pitié-Salpêtrière Hospital, Paris, France.
Bassez G; Institute of Myology, Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
Gargiulo M; Institute of Myology, Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.; Laboratory of Clinical Psychology, Psychopathology, and Psychoanalysis (EA 4056) Paris Descartes University - Sorbonne Paris Cité, Paris, France.
Louët E; Laboratory of Clinical Psychology, Psychopathology, and Psychoanalysis (EA 4056) Paris Descartes University - Sorbonne Paris Cité, Paris, France.
Berrih-Aknin S; UMRS 974 UPMC, INSERM, FRE 3617 CNRS, AIM, Centre of Research in Myology, Paris, France.
Jobic A; Unité de Recherche Clinique Paris ÎIle- de- France Ouest (URCPO), Ambroise Paré Hospital, Boulogne Billancourt, France.; Raymond Poincaré Hospital, AP-HP, Garches, France.
Aegerter P; Unité de Recherche Clinique Paris ÎIle- de- France Ouest (URCPO), Ambroise Paré Hospital, Boulogne Billancourt, France.; Raymond Poincaré Hospital, AP-HP, Garches, France.; UVSQ, UMR-S 1168, Université Versailles St-Quentin-en-Yvelines, Versailles, France.; INSERM, U1168 VIMA, Villejuif, France.
Thoumie P; Rothschild Hospital, AP-HP, Paris, France.
Sharshar T; Intensive Care Unit, Raymond Poincaré Hospital, AP-HP, Garches, France. .; University of Versailles, Saint-Quentin-en-Yvelines, France. .; Department of Histopathology and Animal Models, Institut Pasteur, Paris, France. .; Pokaż więcej
Corporate Authors:: MGEX Study Group
Źródło:: Trials [Trials] 2018 Jan 18; Vol. 19 (1), pp. 49. Date of Electronic Publication: 2018 Jan 18.
Typ publikacji:: Clinical Trial Protocol; Journal Article
MeSH Terms:: Exercise Tolerance*
Exercise Therapy/*methods
Muscle, Skeletal/*physiopathology
Myasthenia Gravis/*therapy
Adolescent ; Adult ; Aged ; Exercise Therapy/adverse effects ; Female ; France ; Health Status ; Humans ; Male ; Middle Aged ; Multicenter Studies as Topic ; Myasthenia Gravis/diagnosis ; Myasthenia Gravis/physiopathology ; Patient Reported Outcome Measures ; Physical Fitness ; Quality of Life ; Randomized Controlled Trials as Topic ; Single-Blind Method ; Time Factors ; Treatment Outcome ; Young Adult